Future Lipidology

Lipid-lowering therapy with statins in postmenopausal women: a few answered and many unanswered questions
pp. 375-379(5)
Authors: Bellasi, Antonio; Raggi, Paolo

Of mice and macrophages
pp. 381-383(3)

Lipid Rafts and Caveolae
pp. 385-387(3)
Authors: Enrich, Carlos; Pol, Albert

Adiposopathy: why do adiposity and obesity cause metabolic disease?
pp. 389-420(32)
Authors: Bays, Harold; Ballantyne, Christie

The ACTIVATE study: lessons for the future of atherosclerotic therapy
pp. 421-428(8)
Authors: Nicholls, Stephen J; Sipahi, Ilke; Schoenhagen, Paul

Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor
pp. 429-440(12)
Author: Aso, Yoshimasa

Lipid metabolism in Alzheimer's and Parkinson's disease
pp. 441-453(13)
Authors: Xu, Qin; Huang, Yadong

Peroxisome proliferator-activated receptor-γ and lipodystrophy
pp. 455-462(8)
Authors: Tamsma, Jouke T; Rabelink, Ton J

Future approaches to reducing low-density lipoprotein cholesterol
pp. 463-476(14)
Author: Wierzbicki, Anthony S

New insights into the regulation of cellular cholesterol efflux and high-density lipoprotein metabolism
pp. 477-486(10)
Authors: Ayaori, Makoto; Kusuhara, Masatoshi; Ohsuzu, Fumitaka

Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterol
pp. 487-500(14)
Authors: Mabuchi, Hiroshi; Inazu, Akihiro